What would you consider to be a successful share buyback? And perhaps more importantly, what would be an acceptable sustained price target for the 2024 AGM to avoid a second strike? I think I would be disappointed if the share price is not in the 25 to 30 dollar range as I think that is a fair value. Furthermore, I expect an announcement that the vitiligo trial is proceeding smoothly, and that management is taking immediate steps to upgrade their US ADR listing in order to take full advantage of the hype train that vitiligo will generate leading up to approval.
What is an acceptable price target by the 2024 AGM?
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.30 |
Change
0.000(0.00%) |
Mkt cap ! $716.1M | |||
| Open | High | Low | Value | Volume |
| $14.21 | $14.33 | $13.69 | $2.607M | 186.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 658 | $14.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.32 | 698 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |